In the Nifty200 pack, 10 stocks’ closing prices crossed above their 200 DMA (Daily Moving Averages) on October 29, 2025, according to stockedge.com’s technical scan data. The 200-day daily moving average (DMA) is used by traders as a key indicator for determining the overall trend in a particular stock. As long as the stock is … Read more
India’s equity indices ended almost 1% lower on Friday, marking their fifth straight week of losses-the longest losing streak in two years-as concerns over the fallout of US tariffs on Indian exports weighed on sentiment. The NSE Nifty fell 0.8% or 203 points to finish at 24,565.35. The BSE Sensex moved 0.7% or 585.67 points … Read more
Drug major Sun Pharmaceutical Industries on Thursday reported a 20% fall in its Q1 consolidated net profit to Rs 2,278 crore compared to Rs 2,836 crore in the year ago period. The company’s revenue from operation stood at Rs 13,786 crore which was up 10% versus Rs 12,525 crore posted in the corresponding quarter of … Read more
Mutual fund investment has become an appealing opportunity for wealth accumulation. A key advantage of this investment avenue is its accessibility, as individuals can start investing with amounts as low as Rs 100 or Rs 200 through Systematic Investment Plans (SIPs). The power of compound interest, given time to grow, has the potential to turn … Read more
MUMBAI – The National Stock Exchange (NSE) of India will launch four new indices in the cash and futures and options segments with effect from April 8. The exchange has proposed online dissemination of indices namely, Nifty Tata Group 25% Cap, Nifty500 Multicap India Manufacturing 50:30:20, Nifty500 Multicap Infrastructure 50:30:20, and Nifty MidSmall Healthcare, according … Read more
Veteran fund manager Rajiv Jain said his GQG Partners LLC holds about $13 billion in India stocks and plans to buy more, downplaying corporate governance and political risks associated with his headline-generating investments in billionaire Gautam Adani’s beleaguered conglomerate. GQG holds positions in companies, including cigarette and hotel group ITC , the country’s biggest drugmaker … Read more
As per the agreement, the pharma majors will jointly sponsor, supervise and monitor the clinical trial in India. Five major pharma companies of India have entered into a collaboration for the clinical trial of oral anti-viral drug Molnupiravir for the treatment of mild COVID-19. Indian pharmaceutical companies that have joined hands for this are – … Read more
Mumbai: Most brokerages have retained a bullish view on despite the company’s March quarter profit missing estimates. Sun Pharmaceutical reported a 123% year-on-year rise in its consolidated net profit for the quarter ended March to ₹894.2 crore. CLSA, HSBC, and Motilal Oswal maintained buy, while Kotak Institutional and IIFL maintained add rating. Jefferies retained underperform. … Read more